In vitro study of intestinal transport of arsenite, monomethylarsonous acid, and dimethylarsinous acid by Caco-2 cell line

Toxicology Letters

Volumn 204, Issue 2-3, 2011, Pages 127-133

  Calatayud, M ^a   Devesa, V ^a   Montoro, R ^a   Velez D ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

Arsenite; Caco 2; Dimethylarsinous acid; Intestinal transport; Monomethylarsonous acid

Indexed keywords

ARSENIC TRIOXIDE; CACODYLIC ACID; GREEN TEA EXTRACT; METHANEARSONIC ACID;

ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE ABSORPTION; PH; PRIORITY JOURNAL; TEMPERATURE;

ARSENITES; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CACODYLIC ACID; GLUTATHIONE; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINES; ORGANOMETALLIC COMPOUNDS; PERMEABILITY; PLANT EXTRACTS; TEA; TEMPERATURE;

EID: 79957995063     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.04.023     Document Type: Article

References (40)

1. Burton C.A., Hatlelid K., Divine K., Carter D.E., Fernando Q., Brendel K., Gandolfi J.A. Glutathione effects on toxicity and uptake of mercuric chloride and sodium arsenite in rabbit renal cortical slices. Environ. Health Perspect. 1995, 103:81-84.
2. Calatayud M., Gimeno J., Vélez D., Devesa V., Montoro R. Characterization of the intestinal absorption of arsenate, monomethylarsonic acid, and dimethylarsinic acid using the Caco-2 cell line. Chem. Res. Toxicol. 2010, 23:547-556.
3. Drobná Z., Waters S.B., Devesa V., Harmon A.W., Thomas D.J., Stýblo M. Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase. Toxicol. Appl. Pharmacol. 2005, 207:147-159.
4. Escudero-Lourdes C., Medeiros M.K., Cárdenas-González M.C., Wnek S.M., Gandolfi J.A. Low level exposure to monomethyl arsonous acid-induced the over-production of inflammation-related cytokines and the activation of cell signals associated with tumor progression in a urothelial cell model. Toxicol. Appl. Pharmacol. 2010, 244:162-173.
5. Heitkemper D.T., Vela N.P., Stewart K.R., Westphal C.S. Determination of total and speciated arsenic in rice by ion chromatography and inductively coupled plasma mass spectrometry. J. Anal. At. Spectrom. 2001, 16:299-306.
6. Hidalgo I.J., Raub T.J., Borchardt R.T. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 1989, 96:736-749.
7. Hidalgo I.J., Borchardt R.T. Transport of a large neutral amino acid (phenylalanine) in a human intestinal epithelial cell line: Caco-2. Biochim. Biophy. Acta Biomembr. 1990, 1028:25-30.
8. Hirano S., Cui X., Li S., Kanno S., Kobayashi Y., Hayakawa T., Shraim A. Difference in uptake and toxicity of trivalent and pentavalent inorganic arsenic in rat heart microvessel endothelial cells. Arch. Toxicol. 2003, 77:305-312.
9. Hubatsch I., Ragnarsson E.G.E., Artursson P. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat. Protoc. 2007, 2:2111-2119.
10. IARC (International Agency for Cancer Research). (2004). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs; International Agency for Cancer Research, Vol. 84, p. 39.
11. Ito K., Suzuki H., Horie T., Sugiyama Y. Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport. Pharm. Res. 2005, 22:1559-1577.
12. Knipp G.T., Ho F.H.N., Barsuhn C.L., Borchardt R.T. Paracellular diffusion in Caco-2 cell monolayers: effect of perturbation on the transport of hydrophilic compounds that vary in charge and size. J. Pharm. Sci. 1997, 86:1105-1110.
13. Kozul C.D., Ely K.H., Enelow R.I., Hamilton J.W. Low-dose arsenic compromises the immune response to influenza A infection in vivo. Environ. Health Perspect. 2009, 117:1441-1447.
14. Kristl A. Membrane permeability in the gastrointestinal tract: the interplay between microclimate pH and transporters. Chem. Biodiv. 2009, 6:1923-1932.
15. Krüger K., Binding N., Straub H., Mußhoff U. Effects of arsenite on long-term potentiation in hippocampal slices from young and adult rats. Toxicol. Lett. 2006, 165:167-173.
16. Laparra J.M., Vélez D., Barberá R., Montoro R., Farré R. An approach to As(III) and As(V) bioavailability studies with Caco-2 cells. Toxicol. In Vitro 2005, 19:1071-1078.
17. Laparra J.M., Vélez D., Barberá R., Farré R., Montoro R. Bioavailability of inorganic arsenic in cooked rice: practical aspects for human health risk assessments. J. Agric. Food Chem. 2005, 53:8829-8833.
18. Laparra J.M., Vélez D., Barberá R., Granero L., Polache A., Montoro R., Farré R. Cytotoxic effect of As(III) in Caco-2 cells and evaluation of its human intestinal permeability. Toxicol. In Vitro 2006, 20:658-663.
19. Leslie E.M., Haimeur A., Waalkes M.P. Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1): evidence that a tri-glutathione conjugate is required. J. Biol. Chem. 2004, 279:32700-32708.
20. Lu Q.-Y., Jin Y.-S., Pantuck A., Zhang Z.-F., Heber D., Belldegrun A., Brooks M., Figlin R., Rao J. Green tea extract modulates actin remodeling via rho activity in an in vitro multistep carcinogenic model. Clin. Cancer Res. 2005, 11:1675-1683.
21. Lu Q.-Y., Yang Y., Jin Y.S., Zhang Z.-F., Heber D., Li F.P., Dubinett S.M., Sondej M.A., Loo J.A., Rao J.Y. Effects of green tea extract on lung cancer A549 cells: proteomic identification of proteins associated with cell migration. Proteomics 2009, 9:757-767.
22. Mårtensson J., Jain A., Meister A. Glutathione is required for intestinal function. PNAS 1990, 87:1715-1719.
23. Mathieu F., Galmier M.J., Pognat J.F., Petit J., Lartigue C. Transepithelial transport of bepridil in the human intestinal cell line, Caco-2, using two media, DMEMc and HBSS. Int. J. Pharm. 1999, 181:203-217.
24. Ménez C., Buyse M., Dugave C., Farinotti R., Barratt G. Intestinal absorption of miltefosine: contribution of passive paracellular transport. Pharm. Res. 2007, 24:546-554.
25. Navas-Acien A., Guallar E. Arsenic exposure and diabetes mellitus in the United States - reply. J. Am. Med. Assoc. 2008, 300:2728-2729.
26. Neuhoff S., Ungell A.-L., Zamora I., Artursson P. pH dependent passive and active transport of acidic drugs across Caco-2 cell monolayers. Pharm. Sci. 2005, 25:211-220.
27. Paul D.S., Harmon A.W., Devesa V., Thomas D.J., Stýblo M. Molecular mechanisms of the diabetogenic effects of arsenic inhibition of insulin signaling by arsenite and methylarsonous acid. Environ. Health Perspect. 2007, 115:734-742.
28. Petrick J.S., Ayala-Fierro F., Cullen W.R., Carter D.E., Vasken Aposhian H. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 2000, 163:203-207.
29. Ryan P., Hynes M.J. The kinetics and mechanisms of the complex formation and antioxidant behaviour of the polyphenols EGCg and ECG with iron(III). J. Inorg. Biochem. 2007, 101:585-593.
30. Shimizu M., Shirakami Y., Sakai H., Yasuda Y., Kubota M., Adachi S., Tsurumi H., Hara Y., Moriwaki H. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells. Chem. Biol. Interact. 2010, 185:247-252.
31. Shore P.A., Brodie B.B., Hogben C.A.M. The gastric secretion of drugs: a pH partition hypothesis. J. Pharmacol. Exp. Ther. 1957, 119:361-369.
32. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Reed W., Wang C., Cullen W., Thomas D. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 2000, 74:289-299.
33. Suzuki K.T., Tomita T., Ogra Y., Ohmichi M. Glutathione-conjugated arsenics in the potential hepato-enteric circulation in rats. Chem. Res. Toxicol. 2001, 14:1604-1611.
34. Tokar E.J., Diwan B.A., Waalkes M.P. Arsenic exposure in utero and nonepidermal proliferative response in adulthood in tg.AC mice. Int. J. Toxicol. 2010, 29:291-296.
35. Valencia E., Marin A., Hardy G. Glutathione - nutritional and pharmacologic viewpoints: part I. Nutrition 2001, 17:428-429.
36. Van de Wiele T., Gallawa C.M., Kubachka K.M., Creed J.T., Basta N., Dayton E.A., Whitacre S., Laing G.D., Bradham K. Arsenic metabolism by human gut microbiota upon in vitro digestion of contaminated soils. Environ. Health Perspect. 2010, 118:1004-1009.
37. Xi S., Sun W., Wang F., Jin Y., Sun G. Transplacental and early life exposure to inorganic arsenic affected development and behavior in offspring rats. Arch. Toxicol. 2009, 83:549-556.
38. Yathavakilla S.K.V., Fricke M., Creed P.A., Heitkemper D.T., Shockey N.V., Schwegel C., Caruso J.A., Creed J.T. Arsenic speciation and identification of monomethylarsonous acid and monomethylthioarsonic acid in a complex matrix. Anal. Chem. 2008, 80:775-782.
39. Yee S. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man - fact or myth. Pharm. Res. 1997, 14:763-766.
40. Zhou Y., Yokel R.A. The chemical species of aluminum influences its paracellular flux across and uptake into Caco-2 cells, a model of gastrointestinal absorption. Toxicol. Sci. 2005, 87:15-26.